MCHX MCHX
Company Profile ↓Company Overview
MCHX (MCHX) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Dec 2025 Revenue of $45.42M (-5.6% YoY); net profit $-5.24M.
- Trailing 12 Months Year-on-year growth — revenue -5.6%.
- 5-Year Trend Long-term compounding — revenue CAGR -4.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -4.40% |
| 1 Year: | -5.61% |
Stock Price Performance
| 1 Year: | -11.65% |
| 6 Months: | +10.30% |
| 3 Months: | +5.81% |
| 1 Month: | +1.68% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- Golden Cross9d ago
- RSI (14)56.04 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -4.4% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2013 | Jun 2013 | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 22.02M | 22.05M | 21.90M | 20.22M | 20.01M | 26.41M | 26.34M | 24.79M | 12.01M | 12.72M | 13.80M | 12.98M | 14.01M | 13.70M | 13.17M | 13.51M | 13.20M | 12.22M | 12.52M | 12.78M | 11.57M | 12.07M | 12.55M | 11.40M | 11.65M | 11.51M | 10.62M |
| Operating Income | 297.00K | -98.00K | 1.01M | 1.44M | 69.00K | 193.00K | -300.00K | -1.47M | 12.00K | -3.66M | -68.71M | -5.82M | -3.52M | -1.31M | -876.00K | -1.16M | -917.00K | -742.00K | -1.60M | -1.27M | -1.35M | -26.58M | -6.08M | -5.68M | -5.25M | -2.86M | -1.90M | -1.53M | -1.50M | -1.60M | -4.50M | -2.70M | -1.32M | -1.31M | -722.00K | -825.00K | -1.87M | -536.00K | -941.00K | -1.35M |
| Net Income | 85.00K | -354.00K | 1.48M | 855.00K | 980.00K | -21.50M | 4.58M | 20.87M | 9.00K | -3.68M | -68.79M | -5.85M | -3.51M | - | - | -926.00K | -658.00K | -457.00K | -1.30M | -1.11M | -1.22M | -24.88M | -4.51M | -3.67M | -5.33M | -333.00K | 3.31M | -1.58M | -1.53M | -1.56M | -4.48M | -2.74M | -1.55M | -1.45M | -756.00K | -831.00K | -1.98M | 84.00K | -1.02M | -1.72M |
| Diluted EPS | 0.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.01 | 0.07 | -0.04 | -0.03 | -0.04 | -0.11 | -0.06 | -0.04 | -0.03 | -0.02 | -0.02 | -0.05 | 0.00 | -0.02 | -0.04 |
| R&D Expense | 6.81M | 6.94M | 6.83M | 7.56M | 7.46M | 7.58M | 7.69M | 8.15M | 7.77M | 7.47M | 7.55M | 6.83M | 5.27M | 4.28M | 4.26M | 3.65M | 3.87M | 3.86M | 4.57M | 5.00M | 5.13M | 5.36M | 5.31M | 5.17M | 5.32M | 4.79M | 3.18M | 3.46M | 3.53M | 3.52M | 4.16M | 4.10M | 3.94M | 3.25M | 3.22M | 3.11M | 2.67M | 2.50M | 2.37M | 2.41M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 93.26M | 97.57M | 138.73M | 132.79M | 147.84M | 173.60M | 143.01M | 129.55M | 90.29M | 85.25M | 54.49M | 51.22M | 53.48M | 52.17M | 49.91M | 48.12M | 45.42M |
| Operating Income | -3.57M | -3.79M | 5.72M | -17.24M | -2.10M | -222.00K | -507.00K | -83.90M | -6.36M | -3.89M | -13.96M | -44.06M | -11.80M | -8.15M | -9.64M | -4.45M | -5.72M |
| Net Income | -2.06M | -3.04M | 2.96M | -35.20M | 1.82M | -19.09M | 26.72M | -84.07M | -6.09M | -2.68M | -4.04M | -38.45M | -4.39M | -8.24M | -9.91M | -4.95M | -5.24M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | -0.10 | -0.19 | -0.23 | -0.11 | -0.12 |
| R&D Expense | 14.48M | 16.80M | 22.60M | 23.20M | 27.33M | 29.56M | 31.06M | 28.45M | 18.09M | 15.42M | 17.88M | 21.00M | 16.11M | 14.36M | 15.36M | 12.41M | 9.75M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 159.69M | 220.06M | 149.15M | 162.15M | 180.67M | 204.99M | 128.27M | 123.82M | 113.06M | 124.50M | 76.93M | 65.83M | 56.79M | 47.48M | 43.20M | 39.68M |
| Total Equity | 149.31M | 141.43M | 139.69M | 159.01M | 122.94M | 134.75M | 156.15M | 187.47M | 113.27M | 90.00M | 95.03M | 99.84M | 52.69M | 51.50M | 44.11M | 35.87M | 32.63M | 30.09M |
| Cash & Equivalents | 27.42M | 33.64M | 37.33M | 37.44M | 15.93M | 30.91M | 80.03M | 109.16M | 103.95M | 104.19M | 45.23M | 41.73M | 33.85M | 27.09M | 20.47M | 14.61M | 12.77M | 9.94M |
| Total Liabilities | - | - | 20.00M | 61.05M | 26.21M | 27.39M | 24.52M | 17.53M | 15.00M | 33.82M | 18.04M | 24.66M | 24.24M | 14.32M | 12.68M | 11.61M | 10.57M | 9.60M |
| Current Liabilities | - | - | 17.92M | 58.47M | 24.00M | 25.30M | 23.40M | 16.86M | 14.87M | 32.73M | 14.77M | 17.55M | 20.95M | 12.67M | 12.06M | 9.72M | 9.27M | 8.06M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 17.15M | 9.39M | 16.78M | 19.90M | 13.60M | 22.42M | 12.75M | -3.67M | 1.69M | 5.05M | 5.09M | -3.37M | -6.34M | -2.29M | -4.39M | -1.10M | -1.41M |
| Investing Cash Flow | 2.54M | 3.22M | -10.39M | 3.32M | 1.65M | -3.18M | 21.82M | -1.22M | -1.58M | -36.56M | -9.68M | 981.00K | -951.00K | -2.87M | -1.31M | -429.00K | -1.32M |
| Financing Cash Flow | -13.46M | -8.92M | -6.28M | -44.73M | -261.00K | 29.88M | -5.45M | -312.00K | 125.00K | -27.45M | 1.89M | -5.49M | 528.00K | -1.46M | -160.00K | -307.00K | -97.00K |
| Capital Expenditure | -2.38M | -3.44M | -3.97M | -2.88M | -3.04M | -3.27M | -4.11M | -986.00K | -1.56M | -1.65M | -1.62M | -1.35M | -1.35M | -2.87M | -1.38M | -382.00K | -36.00K |
| Free Cash Flow | 14.76M | 5.95M | 12.81M | 17.02M | 10.55M | 19.15M | 8.65M | -4.66M | 130.00K | 3.40M | 3.47M | -4.73M | -7.69M | -5.16M | -5.77M | -1.49M | -1.44M |
| Share Buybacks | 10.72M | 6.53M | 6.16M | 1.65M | 119.00K | 2.49M | 3.82M | 365.00K | - | 5.67M | - | 10.85M | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | -3.8% | -3.9% | 4.1% | -13.0% | -1.4% | -0.1% | -0.4% | -64.8% | -7.0% | -4.6% | -25.6% | -86.0% | -22.1% | -15.6% | -19.3% | -9.2% | -12.6% |
| Net Margin % | -2.2% | -3.1% | 2.1% | -26.5% | 1.2% | -11.0% | 18.7% | -64.9% | -6.7% | -3.1% | -7.4% | -75.1% | -8.2% | -15.8% | -19.9% | -10.3% | -11.5% |
| ROE % | -1.5% | -2.2% | 1.9% | -28.6% | 1.3% | -12.2% | 14.3% | -74.2% | -6.8% | -2.8% | -4.0% | -73.0% | -8.5% | -18.7% | -27.6% | -15.2% | -17.4% |
| ROCE % | - | -2.7% | 3.5% | -13.8% | -1.5% | -0.1% | -0.3% | -74.0% | -7.0% | -4.0% | -13.1% | -78.7% | -22.2% | -18.2% | -25.5% | -13.1% | -18.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MCHX
Marchex Will Post Q2 Results Before a 5 p.m. Investor Call - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOaW0xdExBQmVYR1RUSVZBRGwxTUhUT2tVZV9sRktQeXJwQUlaanlNSGxkS0VGeG1iNk5oQU4zZEE1S1d5ZGYwOUxDX3hSSTZFc1UwanB6QzRTR0N3d3d0OEp3OEJ5UUhkcmlwbGtZcENBTm53Tk1WSndKZWtQeXhvOERPa3NYQVYyLWZ6LT…
GoDaddy Inc. Cl A stock outperforms competitors on strong trading day - MarketWatch
<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxNMWpYYk9hR3N6TzNRdjE1ZmgtQXd6S1BSQkFPeEZ0bE45U3UxQlpERnpFRmYzZnhyZi15cEJWSnlsMzRSbThNX251Y0daTm1kLUZSdnRNc3p1dkRHMkM2V1dQdFZwYno0enFLc3dDSEJUV21raHQtMDU5SkVQMTcxVGJSaTcydGRtM2xaQ2…
MCHX|Marchex Inc|Price:1.849|Chg%:+0.129 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFByNVdCeUs2alVvUXphcVRvaGc5NEphbU4wYjllbmU2VWJyRUZKSmdtd3I2V0JOREZNUDlQS0R3Y0NneVkzU2hiODlLdXdaMW9SQTU0Zk5yRkZoTGtaeDFkaHE2LWVRQzRCLVFCUzVn?oc=5" target="_blank">MCHX|Marchex Inc|Pr…
Marchex (MCHX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxPclRPNVAtc2tFZ01sN1NZMDRTU1JvaTlVVDNtdnNxY1FHYVFUaUZ4NGpuMlgzMGhadHZsTkxLOUhlMDJWZldLOG1PYVBGMjhlUU4tVlhUd1otVVB0bEp4UUdFbGN0ZTNoQWI3N3JTcURRdUtWdDJiQklSWXpkTTRTRW5lcWxhNVhDeVZyOG…
Russell C. Horowitz Discloses Investment at Marchex with 18.5% Stake - TradingView
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxOdWVpcDJNWGEycGFzZEl0VlJQOFhGX01CbjdHNnAwelc2TDJZTHRzTS1zUUlZbFdxbHdhSERfV3NnOVlUdTByUWlKYWhjZTEwekdyYThoNFFZSHQ5YlVyZG5xRTRHVUJPS3ZlYUNfQ3h5dU9PV2YwZmx2SjV0NUN0UW8zajFBaVF2eGhsR1…
Marchex (MCHX) Completes Acquisition of Archenia to Enhance AI S - GuruFocus
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNNVBTR2hGcnF2NHh3T2l3R3JKXy1ncWw3YjN2elEzREZWZl9KZWFSS0RpTnVod2lGNHY2R0JDYnlPNEVyMWdFTWdvRGt1RVJjTE9jbGRNUUhLSVQ3dy13T1lDaHBCck52WHVLNnRaUmowSDhSdEc1ZGNoRzhZNGN4OHVjdThnOHN6YjZNeW…
MCHX — Frequently Asked Questions
What is the current share price of MCHX?
As of 2026-08-05 17:25 PDT, MCHX trades at $1.82 on NASDAQ/NYSE. Its 52-week range is $1.34 to $2.13.
What is the P/E ratio of MCHX?
MCHX trades at a trailing price-to-earnings (P/E) ratio of -15.17.
What is the return on equity (ROE) of MCHX?
MCHX has a return on equity (ROE) of -17.40%. Its return on capital employed (ROCE) is -18.11%.
Is MCHX a good stock to buy?
This page provides a data-driven analysis of MCHX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.